GALWAY - Quidel Corporation (NASDAQ: QDEL) a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, celebrated opening its new Business Service Centre in Galway city today. The celebration marks the company’s first expansion into international facilities.
The new office will support Quidel’s growing international business, a portfolio that has experienced substantial growth due to the recent acquisition of Alere’s Triage® business.
New jobs created at the Galway facility include roles in Finance, Human Resources, Customer, Service, Technical Support, Sales, IT and Legal. Hiring is ramping up quickly as Quidel works with the IDA in recruiting local talent to support its new international business, targeting the creation of 75 jobs over five years.
The project is supported by the Irish Government through IDA Ireland.
The company, headquartered in San Diego, California, employs approximately 1,200 people in operations in North America, Europe, Latin America, Japan, and other parts of Asia.
“Since our acquisition of Alere's Triage business in October, Quidel’s international presence has increased markedly, and we’re investing throughout the world to support our international growth, especially in the European region,” said Douglas Bryant, Quidel Corporation’s President and CEO. “We are proud to partner with Martin Shanahan and IDA Ireland to bring jobs to Galway, and are pleased that our new Galway facility will serve as the headquarters for our European commercial operations.”
Speaking at the company’s office opening event, Mayor Niall McNelis said: “I’m delighted to join with you to celebrate the official opening of your new offices. It reaffirms Quidel’s commitment to Galway and the West region. As the hub for your international business, this new Business Service Centre represents an exciting and progressive milestone in your growth. I wish you, and all who come to work here, every success.”
IDA Ireland’s Head of Life Sciences Michael Lohan said: “Having announced your plans in February to establish headquarters here in Galway for your European commercial operations, I'm delighted to be here today to mark the opening of your new permanent offices in the heart of the city. We are delighted to welcome you as a new name investor in the innovative medical device space to Galway and Ireland. The activities and roles you are creating, and I understand a number of staff have already been recruited, are high value service roles which will greatly benefit the economy of the region.”
Quidel is excited to partner with Collins McNicholas on the recruiting efforts for the Galway business centre. For more information on open roles go to: www.collinsmcnicholas.ie/quidel
About the Company
Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the Sofia®, QuickVue®, D3® Direct Detection, Thyretain®, Triage® and InflammaDry® leading brand names, as well as under the new Solana®, AmpliVue® and Lyra® molecular diagnostic brands, Quidel’s products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza, respiratory syncytial virus, Strep A, herpes, pregnancy, thyroid disease and fecal occult blood. Quidel's recently acquired Triage® system of tests comprises a comprehensive test menu that provides rapid, cost-effective treatment decisions at the point-of-care (POC), offering a diverse immunoassay menu in a variety of tests to provide healthcare providers with diagnostic answers for quantitative BNP, CK-MB, d-dimer, myoglobin, troponin I and qualitative TOX Drug Screen. Quidel’s research and development engine is also developing a continuum of diagnostic solutions from advanced immunoassay to molecular diagnostic tests to further improve the quality of healthcare in physicians’ offices, hospital and reference laboratories, and other alternate sites, like urgent care centres and retail clinics, where healthcare is provided.
For more information about Quidel’s comprehensive product portfolio, visit www.quidel.com
Ellen Lynch, Regional Communications Press & PR Executive
firstname.lastname@example.org +353 87 4112084